Commercialization and Reimbursement are Topics of the Fogarty Institute’s First Virtual Workshop

To effectively introduce a new product to market and ensure it is widely adopted, medtech companies must consider the many facets of their go-to-market strategy from the earliest days of product development.

This was the message of the Fogarty Institute’s third-annual educational workshop focused on commercialization. The three-part seminar series, being presented virtually to adhere to COVID restrictions,

Raydiant Oximetry Executive Team Spearheads the Launch of Ventilator Company Respirana

When Neil Ray, MD, founder and CEO of FII graduate Raydiant Oximetry and a board-certified anesthesiologist, learned about the global shortage of ventilators early in the COVID-19 crisis, he immediately considered ways that he, his colleagues and others in the Silicon Valley medtech ecosystem could help.

He first reached out to Russ DeLonzor,

Q&A with Mark Leahey, MDMA CEO and Fogarty Institute Board Member

As the Medical Device Manufacturers Association (MDMA) continues to take the lead in representing the interest of medtech companies, we wanted to sit down and talk with president and CEO, and Fogarty Institute board member, Mark Leahey, about the current landscape. MDMA is an incredibly nimble and effective organization – just like its constituents – and has been a beacon during the COVID-19 crisis,

UCSF-Stanford Pediatric Device Consortium Pitch Competition a Virtual Success

Innovation can’t be stopped by a quarantine. The 2020 annual UCSF-Stanford Pediatric Device Consortium Pitch Competition, originally scheduled to take place at the Stanford University School of Medicine, went off seamlessly in a virtual, but still highly interactive format last month.

The Pediatric Device Consortium (PDC) felt it was critical to hold the competition as planned in order to support the much-needed development of health technologies for children,

New Fogarty Company Addresses $1.75 Billion Chronic Sinusitis Market

Imagine having a really bad cold that never goes away—congestion, runny nose, facial pressure, headache and loss of smell for more than three months. That’s what it feels like to the more than 36 million people in the U.S. who suffer from chronic rhinosinusitis (CRS), a persistent inflammatory condition of the nasal and sinus cavity lining.

Spotlight: Fred St Goar, FII Vice Chairman of the Board

When he is not helping a patient, mentoring entrepreneurs at Stanford Biodesign, supporting the Fogarty Institute as a board member or assessing how to develop a new medical device, Fred St Goar, MD, is looking for ways to help improve the global health system. Through a lifetime of fascinating medical experiences, he is well-equipped to wear all those hats equally well.

Fundraising Workshop Generates Strong Interest Among Entrepreneurs and Medtech Community

It was a full house at the Fogarty Institute’s latest educational seminar titled “Fundraising – Art or Science?” highlighting the need and interest in this important topic. After all, it drives the future of all startups, but is particularly pertinent to early-stage companies immersed in finding appropriate funding.*

Attendees were also drawn to the breadth of experience of the speakers,

A $2 Million Grant From the National Cancer Institute A Highlight of a Noteworthy Year for EnSpectra Health

It has been an action-packed 12 months for EnSpectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology. While 2019 brought a number of notable developments, most recently EnSpectra received a $2 million grant that will expedite the introduction of its groundbreaking skin cancer identification technology.

Spotlight: Gordon Saul, Executive Director at Stanford Byers Center for Biodesign

When healthcare innovation drives you, the possibilities are endless. Like many successful healthtech entrepreneurs, Gordon Saul has worn many hats throughout his career, experiencing the industry from many different angles. Today, he is an integral part of an incredibly talented team as executive director at Stanford Byers Center for Biodesign, an organization that we are honored to have been partnering and collaborating with for many years.

START TYPING AND PRESS ENTER TO SEARCH